Sunday, 09 May 2021 09:47 PM MYT
Breton also said he expected that the costs of the EU’s recent order for more doses of Pfizer-BioNTech vaccines would be higher than the earlier versions. “We did not renew the order after June. We’ll see what happens,” said Breton, adding that it was “a very good vaccine”.Europe’s medicines regulator said on Friday it is reviewing reports of a rare nerve-degenerating disorder in people who received the shots, a move that comes after it found the vaccine may have caused very rare blood clotting cases.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше: